Logo image of ELA

ENVELA CORP (ELA) Stock Fundamental Analysis

USA - NYSEARCA:ELA - US29402E1029 - Common Stock

7.05 USD
-0.04 (-0.56%)
Last: 9/12/2025, 8:04:00 PM
7.05 USD
0 (0%)
After Hours: 9/12/2025, 8:04:00 PM
Fundamental Rating

7

Taking everything into account, ELA scores 7 out of 10 in our fundamental rating. ELA was compared to 121 industry peers in the Specialty Retail industry. ELA scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ELA is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! This makes ELA very considerable for growth and quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

ELA had positive earnings in the past year.
In the past year ELA had a positive cash flow from operations.
In the past 5 years ELA has always been profitable.
ELA had a positive operating cash flow in each of the past 5 years.
ELA Yearly Net Income VS EBIT VS OCF VS FCFELA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

1.2 Ratios

Looking at the Return On Assets, with a value of 10.31%, ELA belongs to the top of the industry, outperforming 83.47% of the companies in the same industry.
Looking at the Return On Equity, with a value of 14.77%, ELA is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
With an excellent Return On Invested Capital value of 11.43%, ELA belongs to the best of the industry, outperforming 80.17% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ELA is in line with the industry average of 12.11%.
Industry RankSector Rank
ROA 10.31%
ROE 14.77%
ROIC 11.43%
ROA(3y)13.47%
ROA(5y)14.62%
ROE(3y)21.28%
ROE(5y)27.31%
ROIC(3y)12.62%
ROIC(5y)13.55%
ELA Yearly ROA, ROE, ROICELA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

With a decent Profit Margin value of 4.30%, ELA is doing good in the industry, outperforming 74.38% of the companies in the same industry.
In the last couple of years the Profit Margin of ELA has grown nicely.
The Operating Margin of ELA (5.18%) is better than 69.42% of its industry peers.
ELA's Operating Margin has improved in the last couple of years.
ELA's Gross Margin of 23.68% is on the low side compared to the rest of the industry. ELA is outperformed by 73.55% of its industry peers.
ELA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.18%
PM (TTM) 4.3%
GM 23.68%
OM growth 3Y-12.44%
OM growth 5Y2.74%
PM growth 3Y-19.3%
PM growth 5Y2.02%
GM growth 3Y3.52%
GM growth 5Y4.39%
ELA Yearly Profit, Operating, Gross MarginsELA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ELA is creating some value.
The number of shares outstanding for ELA has been reduced compared to 1 year ago.
Compared to 5 years ago, ELA has less shares outstanding
ELA has a better debt/assets ratio than last year.
ELA Yearly Shares OutstandingELA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ELA Yearly Total Debt VS Total AssetsELA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 8.23 indicates that ELA is not in any danger for bankruptcy at the moment.
The Altman-Z score of ELA (8.23) is better than 95.87% of its industry peers.
ELA has a debt to FCF ratio of 1.73. This is a very positive value and a sign of high solvency as it would only need 1.73 years to pay back of all of its debts.
ELA's Debt to FCF ratio of 1.73 is fine compared to the rest of the industry. ELA outperforms 78.51% of its industry peers.
A Debt/Equity ratio of 0.17 indicates that ELA is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.17, ELA is doing good in the industry, outperforming 64.46% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 1.73
Altman-Z 8.23
ROIC/WACC1.21
WACC9.42%
ELA Yearly LT Debt VS Equity VS FCFELA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M 50M

2.3 Liquidity

A Current Ratio of 4.58 indicates that ELA has no problem at all paying its short term obligations.
ELA's Current ratio of 4.58 is amongst the best of the industry. ELA outperforms 97.52% of its industry peers.
A Quick Ratio of 2.36 indicates that ELA has no problem at all paying its short term obligations.
ELA's Quick ratio of 2.36 is amongst the best of the industry. ELA outperforms 93.39% of its industry peers.
Industry RankSector Rank
Current Ratio 4.58
Quick Ratio 2.36
ELA Yearly Current Assets VS Current LiabilitesELA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 37.50% over the past year.
The Earnings Per Share has been growing by 20.12% on average over the past years. This is a very strong growth
Looking at the last year, ELA shows a very strong growth in Revenue. The Revenue has grown by 25.43%.
The Revenue has been growing by 17.07% on average over the past years. This is quite good.
EPS 1Y (TTM)37.5%
EPS 3Y-12.25%
EPS 5Y20.12%
EPS Q2Q%83.33%
Revenue 1Y (TTM)25.43%
Revenue growth 3Y8.56%
Revenue growth 5Y17.07%
Sales Q2Q%21.15%

3.2 Future

ELA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.07% yearly.
Based on estimates for the next years, ELA will show a quite strong growth in Revenue. The Revenue will grow by 10.18% on average per year.
EPS Next Y39.99%
EPS Next 2Y24.07%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year18.32%
Revenue Next 2Y10.18%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ELA Yearly Revenue VS EstimatesELA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
ELA Yearly EPS VS EstimatesELA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4 0.5

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 21.36, which indicates a rather expensive current valuation of ELA.
Based on the Price/Earnings ratio, ELA is valued a bit cheaper than the industry average as 72.73% of the companies are valued more expensively.
ELA's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.30.
Based on the Price/Forward Earnings ratio of 18.32, the valuation of ELA can be described as rather expensive.
Based on the Price/Forward Earnings ratio, ELA is valued a bit cheaper than 65.29% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.73. ELA is around the same levels.
Industry RankSector Rank
PE 21.36
Fwd PE 18.32
ELA Price Earnings VS Forward Price EarningsELA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ELA.
ELA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ELA is cheaper than 71.07% of the companies in the same industry.
Industry RankSector Rank
P/FCF 24.31
EV/EBITDA 14.4
ELA Per share dataELA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ELA has a very decent profitability rating, which may justify a higher PE ratio.
ELA's earnings are expected to grow with 24.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.53
PEG (5Y)1.06
EPS Next 2Y24.07%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ELA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ENVELA CORP

NYSEARCA:ELA (9/12/2025, 8:04:00 PM)

After market: 7.05 0 (0%)

7.05

-0.04 (-0.56%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners13.65%
Inst Owner Change7.31%
Ins Owners49.42%
Ins Owner Change0.31%
Market Cap183.09M
Analysts80
Price Target10.2 (44.68%)
Short Float %3.54%
Short Ratio4.39
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)54.5%
Min EPS beat(2)41.44%
Max EPS beat(2)67.56%
EPS beat(4)4
Avg EPS beat(4)44.08%
Min EPS beat(4)18.81%
Max EPS beat(4)67.56%
EPS beat(8)6
Avg EPS beat(8)21.46%
EPS beat(12)8
Avg EPS beat(12)27.4%
EPS beat(16)12
Avg EPS beat(16)29.08%
Revenue beat(2)2
Avg Revenue beat(2)9.1%
Min Revenue beat(2)2.14%
Max Revenue beat(2)16.06%
Revenue beat(4)4
Avg Revenue beat(4)14.28%
Min Revenue beat(4)2.14%
Max Revenue beat(4)21.16%
Revenue beat(8)6
Avg Revenue beat(8)5.22%
Revenue beat(12)9
Avg Revenue beat(12)5.09%
Revenue beat(16)12
Avg Revenue beat(16)8.2%
PT rev (1m)5.26%
PT rev (3m)5.26%
EPS NQ rev (1m)0.79%
EPS NQ rev (3m)-20%
EPS NY rev (1m)8.28%
EPS NY rev (3m)8.28%
Revenue NQ rev (1m)1.18%
Revenue NQ rev (3m)24.97%
Revenue NY rev (1m)5.15%
Revenue NY rev (3m)6.33%
Valuation
Industry RankSector Rank
PE 21.36
Fwd PE 18.32
P/S 0.92
P/FCF 24.31
P/OCF 16.78
P/B 3.17
P/tB 3.63
EV/EBITDA 14.4
EPS(TTM)0.33
EY4.68%
EPS(NY)0.38
Fwd EY5.46%
FCF(TTM)0.29
FCFY4.11%
OCF(TTM)0.42
OCFY5.96%
SpS7.64
BVpS2.22
TBVpS1.94
PEG (NY)0.53
PEG (5Y)1.06
Profitability
Industry RankSector Rank
ROA 10.31%
ROE 14.77%
ROCE 14.62%
ROIC 11.43%
ROICexc 16.93%
ROICexgc 20.06%
OM 5.18%
PM (TTM) 4.3%
GM 23.68%
FCFM 3.8%
ROA(3y)13.47%
ROA(5y)14.62%
ROE(3y)21.28%
ROE(5y)27.31%
ROIC(3y)12.62%
ROIC(5y)13.55%
ROICexc(3y)17.69%
ROICexc(5y)18.43%
ROICexgc(3y)21.62%
ROICexgc(5y)22.7%
ROCE(3y)16.14%
ROCE(5y)17.45%
ROICexcg growth 3Y-9.57%
ROICexcg growth 5Y-0.97%
ROICexc growth 3Y-7.64%
ROICexc growth 5Y1.09%
OM growth 3Y-12.44%
OM growth 5Y2.74%
PM growth 3Y-19.3%
PM growth 5Y2.02%
GM growth 3Y3.52%
GM growth 5Y4.39%
F-Score7
Asset Turnover2.4
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 1.73
Debt/EBITDA 0.8
Cap/Depr 192.86%
Cap/Sales 1.7%
Interest Coverage 26.86
Cash Conversion 90.66%
Profit Quality 88.29%
Current Ratio 4.58
Quick Ratio 2.36
Altman-Z 8.23
F-Score7
WACC9.42%
ROIC/WACC1.21
Cap/Depr(3y)141.77%
Cap/Depr(5y)313.83%
Cap/Sales(3y)1.17%
Cap/Sales(5y)2.18%
Profit Quality(3y)69.25%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.5%
EPS 3Y-12.25%
EPS 5Y20.12%
EPS Q2Q%83.33%
EPS Next Y39.99%
EPS Next 2Y24.07%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)25.43%
Revenue growth 3Y8.56%
Revenue growth 5Y17.07%
Sales Q2Q%21.15%
Revenue Next Year18.32%
Revenue Next 2Y10.18%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y31.97%
EBIT growth 3Y-4.94%
EBIT growth 5Y20.28%
EBIT Next Year58.11%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y49.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y70.33%
OCF growth 3Y53.73%
OCF growth 5YN/A